ArticleFrontiers in pediatrics2025
Robotic-assisted thoracoscopic surgery in children: a safe approach to remove thoracic tumors.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Robot-Assisted Resection of Mediastinal Tumors in Pediatric Patients: A Systematic Review.Children (Basel, Switzerland) · 2026Review
- Subcostal single-port robot-assisted resection of a posterior mediastinal tumor in an infant.General thoracic and cardiovascular surgery · 2026Article
- Robot-assisted versus conventional minimally invasive surgery in the treatment of paediatric neuroblastoma: a single-centre retrospective study.Pediatric surgery international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Robotic-assisted thoracoscopic surgery (RATS) in children remains a challenge, particularly in oncological cases. This study aims to provide practical and useful insights to enhance the safety and efficacy of this surgical approach. Methods: This is a single-center retrospective analysis conducted over a four-year period (2020-2025), including all pediatric patients (aged 0-18 years) who underwent RATS for thoracic tumor resection with a minimum follow-up of six months. Results: We reviewed 20 cases from pediatric patients who underwent RATS for the removal of thoracic tumors. One patient required a second procedure, totaling 21 surgeries. Neuroblastic tumors were the most frequently treated tumor (50%). The youngest patient was 16 months old, with a median age at surgery of 5 years (IQR: 14-4). The smallest patient weighed 11 kg at surgery with a median weight at surgery of 25 kg (IQR: 49.5-17). A maximum of four trocars were used. Selective ventilation was required only in 5 cases. The median operative time was 135 min (IQR: 100-180). The largest resected lesion measured 63 × 45 × 94 mm and was removed from a 3-year-old patient. Complete tumor resection was achieved in 19 patients. Conversion to open surgery was necessary in 4 cases (19%), primarily due to the need for manual tumor manipulation to ensure proper delineation. Two complications (10%) were recorded, both cases of chylothorax (Clavien-Dindo grades 2). Two patients died due to Ewing sarcoma recurrence, while all others are off therapy and in follow-up; five patients (25%) received adjuvant treatment after surgery. Discussion: Robotic surgery is a viable and safe option for pediatric thoracic tumors in selected cases. In our experience, the technique appeared suitable for all the types of tumors we have been treating, though broader applicability remains to be confirmed. However, RATS should be carefully considered in cases involving deeply infiltrating intrapulmonary lesions, major vascular involvement, or tumors requiring rib resection. Additionally, we believe single-lung ventilation is generally unnecessary unless intrapulmonary tumors are present.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.